Who Are The Major Shareholders Of BioDelivery Sciences International Inc (NASDAQ:BDSI)?

The big shareholder groups in BioDelivery Sciences International Inc (NASDAQ:BDSI) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, ‘Don’t tell me what you think, tell me what you have in your portfolio.’

With a market capitalization of US$166.8m, BioDelivery Sciences International is a small cap stock, so it might not be well known by many institutional investors. Taking a look at the our data on the ownership groups (below), it’s seems that institutions own shares in the company. We can zoom in on the different ownership groups, to learn more about BDSI.

View our latest analysis for BioDelivery Sciences International

NasdaqCM:BDSI Ownership Summary October 1st 18
NasdaqCM:BDSI Ownership Summary October 1st 18

What Does The Institutional Ownership Tell Us About BioDelivery Sciences International?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

We can see that BioDelivery Sciences International does have institutional investors; and they hold 30.5% of the stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It’s therefore worth looking at BioDelivery Sciences International’s earnings history, below. Of course, the future is what really matters.

NasdaqCM:BDSI Income Statement Export October 1st 18
NasdaqCM:BDSI Income Statement Export October 1st 18

It looks like hedge funds own 25.3% of BioDelivery Sciences International shares. That’s interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of BioDelivery Sciences International

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.